OGN News and Press, Organon & Co. From 01/29/26

Organon (NYSE: OGN), a global healthcare company with a primary focus on women’s health, will release its fourth quarter and full year 2025 financial results on February 12, 2026, prior to the company’s webcast and conference call scheduled for 8:30 a.m. ET. IPR&D and Mile...

Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today the successful closing of the sale of its JADA ® System to Laborie Medical Technologies Corp. Please see our prior announcement for ...

2026-01-24 15:15:59 ET More on related tickers, etc. Clorox: Adding Sanitizers, But In Need Of Getting Its Hands Dirty PayPal Looks Dirt Cheap, But It May Never Recover Its Mojo (Downgrade) The Clorox Company (CLX) GOJO Industries, Inc., - M&A Call - Slideshow ...

2026-01-21 21:34:46 ET Since my October article , "My 5 Biggest Biotech Stocks Big Pharma Can Buy Now", Alvotech stock ( ALVO ) has fallen 44%, underperforming the S&P 500 [2.2% return] ( SPY ).... Read the full article on Seeking Alpha For further details se...

2026-01-20 16:15:00 ET Experienced and novice investors alike may want to consider pharmaceutical exchange-traded funds (ETFs) as a way to gain exposure to the top pharma companies and the pharma market as a whole. Like all ETFs, pharmaceutical ETFs are a good option for those who w...

2026-01-20 09:38:06 ET More on Organon Organon: Deep Value With No Clear Catalysts Organon & Co. (OGN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript Organon: Q3 Earnings Lift Struggling Stock - But Not For Long, I Suspect Organon ...

2026-01-17 08:41:22 ET More on Organon Organon: Deep Value With No Clear Catalysts Organon & Co. (OGN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript Organon: Q3 Earnings Lift Struggling Stock - But Not For Long, I Suspect Organon ...

Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today that the US Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for NEXPLANON ® (etonogestrel imp...

2026-01-16 12:21:12 ET Read the full article on Seeking Alpha For further details see: XPH: Healthcare Dashboard For January

2026-01-08 12:22:22 ET More on Organon Organon: Deep Value With No Clear Catalysts Organon & Co. (OGN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript Organon: Q3 Earnings Lift Struggling Stock - But Not For Long, I Suspect Organon ...